Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07515586 · ClinicalTrials.gov registry record · NA
A Mindfulness-based Intervention for Sexual Assault Survivors
A NA study, sponsored by Georgia State University.
- Not yet
- Registry status
- NA
- Development phase
- 120
- Enrollment target
NCT07515586: Clinical Trial NA study, sponsored by Georgia State University.
NCT07515586 is a NA study that has not yet begun recruiting, run by Georgia State University. The registered enrollment target is 120 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (91% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07515586, a NA study, has not yet begun recruiting, sponsored by Georgia State University.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 120 participants
- Enrollment target
Study Summary
The goal is this pilot randomized trial is to learn if intervention 1 is feasible and acceptable. As a secondary goal, we aim to learn if intervention 1 reduces alcohol misuse and tobacco use in sexual assault survivors. The main questions it aims to answer are: * Is intervention 1 feasible to implement? * Is intervention 1 an acceptable intervention among the primary population, sexual assault survivors? * Does intervention 1 reduce alcohol misuse and tobacco use? Researchers will compare intervention 1 to an attention-placebo control group (e.g., online resources on healthy eating and nutrition). Participants will: * take online surveys at baseline, 1 month follow-up, and 3-month follow-up * answer text-message questions at baseline and post-test * view and engage in an educational program
Primary Outcome
Feasibility of the sample is assessed by recruitment and retention of at least 70% participants at 3 month follow-up
Interventions
- BEHAVIORAL Intervention 1
- BEHAVIORAL comparison intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 120 participants |
| Start Date | 2027-10 |
| Est. Completion | 2030-08 |
| Phase | NA |
What is known before NCT07515586 opens enrollment
NCT07515586 is an interventional study that assigns participants to a tested intervention. The registered 120 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (91% lower).
The record links to 0 conditions, and to 2 interventions - of which Intervention 1 is the first listed.
NCT07515586 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07515586 about?
NCT07515586 is a clinical study titled "A Mindfulness-based Intervention for Sexual Assault Survivors". The goal is this pilot randomized trial is to learn if intervention 1 is feasible and acceptable. As a secondary goal, we aim to learn if intervention 1 reduces alcohol misuse and tobacco use in sexual assault survivors. The main questions it aims to answer are: * Is intervention 1 feasible to impl...
What is the current status of trial NCT07515586?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 120 participants. The study started on 2027-10. Estimated completion is 2030-08.
What interventions are being tested in trial NCT07515586?
The interventions under investigation include: Intervention 1 (BEHAVIORAL), comparison intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT07515586?
This trial is sponsored by Georgia State University, which has 45 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07515586's enrollment target sits among peer trials
120 762nd of 2000 higher than 1,198 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01174108 · 120 participants · Phase 2
Allogeneic Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia and Other Bone Marrow Failure Syndromes Using G-CSF Mobilized CD34+ Selected Hematopoietic Precursor Cells Co-Infused With a Reduced Dose of Non-Mobilized Donor T-cells
- NCT01627301 · 120 participants · NA
Sympathetic Overactivity in Post-traumatic Stress Disorder
- NCT02025023 · 120 participants · Phase 3
Local 5-Fluorouracil Injection for the Treatment of Chalazia: A Prospective, Comparative Study
- NCT02128906 · 120 participants · Phase 2
Radiotherapy With Cisplatin vs. Docetaxel-cetuximab in HNSCC: ERCC1 Biomarker Enrichment and Interaction Design
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia